Recordati Industria Chimica e Farmaceutica Balance Sheet Health
Financial Health criteria checks 4/6
Recordati Industria Chimica e Farmaceutica has a total shareholder equity of €1.9B and total debt of €1.5B, which brings its debt-to-equity ratio to 81.6%. Its total assets and total liabilities are €4.2B and €2.3B respectively. Recordati Industria Chimica e Farmaceutica's EBIT is €698.4M making its interest coverage ratio 9.3. It has cash and short-term investments of €235.0M.
Key information
81.6%
Debt to equity ratio
€1.53b
Debt
| Interest coverage ratio | 9.3x |
| Cash | €235.02m |
| Equity | €1.88b |
| Total liabilities | €2.33b |
| Total assets | €4.20b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0KBS's short term assets (€1.3B) exceed its short term liabilities (€906.7M).
Long Term Liabilities: 0KBS's short term assets (€1.3B) do not cover its long term liabilities (€1.4B).
Debt to Equity History and Analysis
Debt Level: 0KBS's net debt to equity ratio (69.1%) is considered high.
Reducing Debt: 0KBS's debt to equity ratio has reduced from 96% to 81.6% over the past 5 years.
Debt Coverage: 0KBS's debt is well covered by operating cash flow (34.6%).
Interest Coverage: 0KBS's interest payments on its debt are well covered by EBIT (9.3x coverage).